A new issue of CCLM is available online! Vol 58, Issue 7

facebook twitter linkedin youtube instagram vimeo
CCLM Vol 58, Issue 7
A new issue of CCLM is available online!
Below the table of contents of the last issue of CCLM, the scientific Journal of EFLM. I do hope you will appreciate this e-mail as a further service by EFLM to our  on-line community.
With kindest regards,
Daniel Rajdl, Chair EFLM Communication Committee
CCLM is published on a monthly basis and is the most relevant Journal on Clinical Chemistry in Europe; it is a valuable and updated source of knowledge for the professionals in the field, well recognized all over the world.

The CCLM 2018 Impact Factor is 3.638.

Click here to access CCLM Vol 58 n. 7 July 2020
In this CCLM issue
Critical role of laboratory medicine in the global response to the COVID-19 pandemic
Khosrow Adeli

Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
Brandon Michael Henry, Maria Helena Santos de Oliveira, Stefanie Benoit, Mario Plebani and Giuseppe Lippi

COVID-19: progression of disease and intravascular coagulation – present status and future perspectives
Job Harenberg and Emmanuel Favaloro

Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence
Mary Kathryn Bohn, Giuseppe Lippi, Andrea Horvath, Sunil Sethi, David Koch, Maurizio Ferrari, Cheng-Bin Wang, Nicasio Mancini, Shannon Steele and Khosrow Adeli

Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations
Giuseppe Lippi, Khosrow Adeli, Maurizio Ferrari, Andrea R. Horvath, David Koch, Sunil Sethi and Cheng-Bin Wang

The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks
Giuseppe Lippi and Mario Plebani

Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)
Giuseppe Lippi, Ana-Maria Simundic and Mario Plebani

Laboratory diagnostics within a modular hospital at the time of Coronavirus disease 2019 (COVID-19) in Wuhan
Liu Yusong, Peng Duanliang, Yang Jia, Chen Dunyan, Jia Hongbing, Yu Siyuan, Chen Huanhuan, Zhao Juan and Liu Lyurong

Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics
Andrea Padoan, Chiara Cosma, Laura Sciacovelli, Diego Faggian and Mario Plebani

Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2)-infected pneumonia (COVID-19)
Chenyao Lin, Jie Xiang, Mingzhe Yan, Hongze Li, Shuang Huang and Changxin Shen

Routine blood tests as a potential diagnostic tool for COVID-19
Davide Ferrari, Andrea Motta, Marta Strollo, Giuseppe Banfi and Massimo Locatelli

Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy
Graziella Bonetti, Filippo Manelli, Andrea Patroni, Alessandra Bettinardi, Gianluca Borrelli, Gianfranco Fiordalisi, Antonio Marino, Annamaria Menolfi, Sara Saggini, Roberta Volpi, Adriano Anesi and Giuseppe Lippi

The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study
Yufen Zheng, Ying Zhang, Hongbo Chi, Shiyong Chen, Minfei Peng, Lifei Luo, Linping Chen, Jun Li, Bo Shen and Donglian Wang

Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
Huan Han, Lan Yang, Rui Liu, Fang Liu, Kai-lang Wu, Jie Li, Xing-hui Liu and Cheng-liang Zhu

The value of urine biochemical parameters in the prediction of the severity of coronavirus disease 2019
Rui Liu, Qingfeng Ma, Huan Han, Hanwen Su, Fang Liu, Kailang Wu, Wei Wang and Chengliang Zhu

COVID-19 infections are also affected by human ACE1 D/I polymorphism
Joris R. Delanghe, Marijn M. Speeckaert and Marc L. De Buyzere

No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infection
Mostafa Saadat

ACE Ins/Del genetic polymorphism and epidemiological findings in COVID-19
Joris R. Delanghe, Marijn M. Speeckaert and Marc L. De Buyzere

Laboratory abnormalities in patients with COVID-2019 infection
Giuseppe Lippi and Mario Plebani

Laboratory abnormalities in children with novel coronavirus disease 2019
Brandon Michael Henry, Giuseppe Lippi and Mario Plebani

Clinical laboratory and SARS-CoV-2 infection: where do we stand?
Claudio Galli and Mario Plebani

Clinical chemistry tests for patients with COVID-19 – important caveats for interpretation
Peter A. Kavsak, Kerstin de Wit and Andrew Worster

Antibody tests for COVID-19: drawing attention to the importance of analytical specificity
Phedias Diamandis, Ioannis Prassas and Eleftherios P. Diamandis

Erythrocyte sedimentation rate is associated with severe coronavirus disease 2019 (COVID-19): a pooled analysis Ivana Lapić, Dunja Rogić and Mario Plebani

One disease, different features: COVID-19 laboratory and radiological findings in three Italian patients
Francesca Tosato, Chiara Giraudo, Michela Pelloso, Giulia Musso, Elisa Piva and Mario Plebani

Decreased “WBC*LYM” was observed in SARS-CoV-2-infected patients from a fever clinic in Wuhan
Chi Zhang, Linjing Zhang, Xing Chen, Hui Zhang and Yang Fei

Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays
Giuseppe Lippi, Gian Luca Salvagno, Manuela Pegoraro, Valentina Militello, Cecilia Caloi, Angelo Peretti, Stefania Gaino, Antonella Bassi, Chiara Bovo and Giuliana Lo Cascio

Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children
Shupeng Jiang, Panpan Liu, Ge Xiong, Zhaohui Yang, Ming Wang, Yan Li and Xue-jie Yu

The friendly use of chloroquine in the COVID-19 disease: a warning for the G6PD -deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene
Ettore D. Capoluongo, Felice Amato and Giuseppe Castaldo

Potential interference of hydroxychloroquine-glucuronide metabolite on therapeutic drug monitoring of hydroxychloroquine using a mass spectrometry detector
Aurelien Millet, Antony Citterio-Quentin, Marie-Claude Gagnieu, Francois Parant and Jerome Guitton

Do you wish to freely access all articles in CCLM?
Become an EFLM Academy Member! Clich here to know more.
European Federation of Clinical Chemistry and Laboratory Medicine
Egmontstraat 11, Brussels
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem?

Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet.

© 2006-2016 ACCLMU. Atlaskit.

To Top